Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
REBBL manufactures and sells organic, plant-powered functional beverages and protein drinks with adaptogens and botanicals for wellness, stress, immunity, and gut health. Products are currently available commercially in major US retail stores; the company donates part of proceeds to anti-human trafficking non-profit Not For Sale. REBBL was acquired by SYSTM in 2022.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on REBBL.